Body composition in premanifest Huntington’s disease reveals lower bone density compared to controls.
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Huntington's disease (HD) is a debilitating autosomal dominant, neurodegenerative disease with a fatal prognosis. Classical features include motor disturbances, dementia and psychiatric problems but are not restricted to this triad as patients often experience other abnormalities such as unintended weight loss, the exact cause of which is unknown. We studied the body composition of 25 premanifest HD and compared it to 25 control subjects using a dual energy x-ray absorptiometer (DEXA) scan. Like the R6/2 transgenic mouse model, we identified significantly lower bone mineral density z-scores in premanifest individuals, that was not related to any difference in testosterone, cortisol, leptin or Vitamin D levels. These results identify an early gene-related change that occurs in HD which not only could lead to a potential biomarker for the disease, but given it is also seen in other manifest neurodegenerative diseases, could also reveal a common disease related process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Even if no obvious evidence for the relationship between osteoporosis and HD is available, bone mineral density is significantly lower in pre-HD carriers than in healthy controls.299”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [299]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
A polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,347
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
Leptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077
Leptin Regulates Bone Formation via the Sympathetic Nervous System
Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., & Karsenty, G. (2002) · Cell · doi:10.1016/s0092-8674(02)01049-8 · Cited by 1,735 · cited 1×
“[32] One of leptin’s functions is to affect bone mass [33] [34] by inducing bone loss, [35] yet again we found no significant difference in leptin levels between study groups.”
BackgroundLeptin regulation of bone resorption by the sympathetic nervous system and CART
Elefteriou, F., Ahn, J. D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Richards, W. G., Bannon, T. W., Noda, M., et al. (2005) · Nature · doi:10.1038/nature03398 · Cited by 1,311 · cited 1×
“[32] One of leptin’s functions is to affect bone mass [33] [34] by inducing bone loss, [35] yet again we found no significant difference in leptin levels between study groups.”
BackgroundRelationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease
Snell, R. G., MacMillan, J. C., Cheadle, J. P., Fenton, I., Lazarou, L. P., Davies, P., MacDonald, M. E., Gusella, J. F., Harper, P. S., & Shaw, D. J. (1993) · Nature Genetics · doi:10.1038/ng0893-393 · Cited by 709
Widespread expression of Huntington's disease gene (IT15) protein product
Sharp, A. H., Loev, S. J., Schilling, G., Li, S.-H., Li, X.-J., Bao, J., Wagster, M. V., Kotzuk, J. A., Steiner, J. P., Lo, A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90345-3 · Cited by 513
Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease
Morton, A. J., Wood, N. I., Hastings, M. H., Hurelbrink, C., Barker, R. A., & Maywood, E. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3842-04.2005 · Cited by 403
Self-citationLuthi-Carter, R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.1911 · Cited by 367
Huntington's disease gene (IT15) is widely expressed in human and rat tissues
Li, S.-H., Schilling, G., Young, W. S., Li, X., Margolis, R. L., Stine, O. C., Wagster, M. V., Abbott, M. H., Franz, M. L., Ranen, N. G., et al. (1993) · Neuron · doi:10.1016/0896-6273(93)90127-d · Cited by 347
The epidemiology of Huntington's disease
Harper, P. (1992) · Human Genetics · doi:10.1007/bf00194305 · Cited by 328
Mouse models of Huntington's disease
Menalled, L. B., & Chesselet, M.-F. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01884-8 · Cited by 315
Relationship between Vitamin D, Parathyroid Hormone, and Bone Health
Sai, A. J., Walters, R. W., Fang, X., & Gallagher, J. C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1886 · Cited by 276
Orexin loss in Huntington's disease
Petersén, Å., Gil, J., Maat-Schieman, M. L. C., Björkqvist, M., Tanila, H., Araújo, I. M., Smith, R., Popovic, N., Wierup, N., Norlén, P., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi004 · Cited by 271
Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: Expanding the phenotype
Klein, C., Pramstaller, P. P., Kis, B., Page, C. E., Kann, M., Leung, J., Woodward, H., Castellan, C. C., Scherer, M., Vieregge, P., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200007)48:1<65::aid-ana10>3.0.co;2-l · Cited by 243
Mochel, F., Charles, P., Seguin, F., Barritault, J., Coussieu, C., Perin, L., Le Bouc, Y., Gervais, C., Carcelain, G., Vassault, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000647 · Cited by 238
Rapid Eye Movement Sleep Disturbances in Huntington Disease
Arnulf, I., Nielsen, J., Lohmann, E., Schieffer, J., Wild, E., Jennum, P., Konofal, E., Walker, M., Oudiette, D., Tabrizi, S., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.482 · Cited by 235
Assessment of the nutrition status of patients with Huntington's disease
Contreras, A. T., Tarrats, R. M., Alonso, M. E., Boll, M., Ochoa, A., & Velásquez, L. (2004) · Nutrition · doi:10.1016/j.nut.2003.10.007 · Cited by 173
Atrophy of the Hypothalamic Lateral Tuberal Nucleus in Huntingtonʼs Disease
Kremer, H. P. H., Roos, R. A. C., Dingjan, G., Bots, G. T. A. M., & Maran, E. (1990) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199007000-00002 · Cited by 172
Björkqvist, M., Fex, M., Renström, E., Wierup, N., Petersén, Å., Gil‐Mohapel, J., Bacos, K., Popović, N., Li, J., Sundler, F., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi053 · Cited by 163
BODY WEIGHT AND DIETARY FACTORS IN HUNTINGTON'S DISEASE PATIENTS COMPARED WITH MATCHED CONTROLS
Sanberg, P. R., Fibiger, H. C., & Mark, R. F. (1981) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1981.tb135681.x · Cited by 161 · cited 1×
“Weight loss commonly occurs in HD and follows a progressive course [25] that begins in premanifest individuals [26] and ends with advanced stage patients experiencing profound cachexia.”
BackgroundDifferential cognitive impairment in alzheimer's disease and huntington's disease
Brandt, J., Folstein, S. E., & Folstein, M. F. (1988) · Annals of Neurology · doi:10.1002/ana.410230605 · Cited by 160
Björkqvist, M., Petersén, Å., Bacos, K., Isaacs, J., Norlén, P., Gil, J., Popovic, N., Sundler, F., Bates, G. P., Tabrizi, S. J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl094 · Cited by 138
Markianos, M., Πάνας, Μ., Kalfakis, N., & Vassilopoulos, D. (2005) · Annals of Neurology · doi:10.1002/ana.20428 · Cited by 134
The metabolic profile of early Huntington's disease- a combined human and transgenic mouse study
Goodman, A. O. G., Murgatroyd, P. R., Medina‐Gómez, G., Wood, N. I., Finer, N., Vidal‐Puig, A., Morton, A. J., & Barker, R. A. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.12.026 · Cited by 133
Self-citationBone Density and Brain Atrophy in Early Alzheimer's Disease
Loskutova, N., Honea, R. A., Vidoni, E. D., Brooks, W. M., & Burns, J. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1185 · Cited by 123
Psychopathology in Huntington's disease patients
Shiwach, R. S. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01587.x · Cited by 117
A prospective evaluation of cognitive decline in early Huntington's disease
Bamford, K. A., Caine, E. D., Kido, D. K., Cox, C., & Shoulson, I. (1995) · Neurology · doi:10.1212/wnl.45.10.1867 · Cited by 117
Popovic, V., Svetel, M., Djurovic, M. N., Petrovic, S., Doknić, M., Pekić, S., Miljić, D., Milic, N. M., Glodic, J., Diéguez, C., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510451 · Cited by 116
Asymptomatic Sleep Abnormalities Are a Common Early Feature in Patients with Huntington’s Disease
Goodman, A. O. G., Rogers, L., Pilsworth, S., McAllister, C., Shneerson, J. M., Morton, A. J., & Barker, R. A. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0163-x · Cited by 111
Self-citationA DNA Segment Encoding Two Genes Very Tightly Linked to Huntington's Disease
Gilliam, T. C., Bućan, M., MacDonald, M. E., Zimmer, M., Haines, J. L., Cheng, S. V., Pohl, T., Meyers, R. H., Whaley, W. L., Allitto, B. A., et al. (1987) · Science · doi:10.1126/science.2890209 · Cited by 109
Huntington's Chorea in Northamptonshire
Oliver, J. E. (1970) · The British Journal of Psychiatry · doi:10.1192/bjp.116.532.241 · Cited by 102
Reduced Limbic and Hypothalamic Volumes Correlate with Bone Density in Early Alzheimer's Disease
Loskutova, N., Honea, R. A., Brooks, W. M., & Burns, J. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1364 · Cited by 94
Fain, J. N. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.2.145 · Cited by 87
Hemachandra Reddy, P., Charles, V., Williams, M., Miller, G., Whetsell, W. O., & Tagle, D. A. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0456 · Cited by 72
Weight loss in Huntington's disease
Stoy, N. S., & McKay, E. M. (2000) · Annals of Neurology · Cited by 31
Localization of rabbit huntingtin using a new panel of monoclonal antibodies.
Wilkinson, F., Nguyen, T., Manilal, S., Thomas, P., Neal, J., Harper, P., Jones, A. L., & Morris, G. (1999) · Brain Research. Molecular Brain Research · doi:10.1016/s0169-328x(99)00097-2 · Cited by 23
Ducharme, N. A. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2010.02.005 · Cited by 12
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice
van der Burg, J. M. M., Winqvist, A., Aziz, N. A., Maat–Schieman, M. L. C., Roos, R. A. C., Bates, G. P., Brundin, P., Björkqvist, M., & Wierup, N. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.006 · Cited by 118
Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients
Wang, R., Ross, C. A., Cai, H., Cong, W., Daimon, C. M., Carlson, O. D., Egan, J. M., Siddiqui, S., Maudsley, S. R., & Martin, B. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00231 · Cited by 83
Zhou, Y. G., Gao, Y., Xu, C., Shen, H., Tian, Q., & Deng, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-19196-2 · Cited by 81
Systemic manifestation and contribution of peripheral tissues to Huntington’s disease pathogenesis
Chuang, C.-L., & Demontis, F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101358 · Cited by 70
Metadata
- Authors
- Goodman, A. O. G., & Barker, R. A.
- Affiliations
- University of Cambridge (GB)
- ORCID
- Barker, Roger A
- Venue
- PLoS Currents
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-02-28
- Volume
- 3
- Pages
- RRN1214
- ISSN
- 2157-3999 (ISSN-L)
- PMC
- PMC3047010
- OpenAlex
- W2119313826
- Cited by
- 28
- References
- 40
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 2 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 3 · 2012: 1
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by
- Locations
- PLoS Currents (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- Huntington's disease, premanifest Huntington's disease, body composition, bone mineral density, bone loss, neurodegeneration, biomarkers, testosterone, cortisol, leptin, vitamin D, weight loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
